Report cover image

IPV Vaccines Market, by Vaccine Brand (POLIOVAC (PFS/SD), SHANIPV, POLIORIX, IPOL/IMOVAX, And POLYMILEX), by Distribution Channel (Private and Public), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Sha

Publisher Coherent Market Insights
Published Mar 04, 2025
Length 220 Pages
SKU # CMI19904757

Description

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.

Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.

Global IPV vaccines market was valued at USD 199.9 Mn in 2025 and is expected to increase to US$ 358.5 Mn by 2032, registering a CAGR of 8.7% over the forecast period.

Market Dynamics

Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2020, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.

Key features of the study:
  • This report provides in-depth analysis of the Global IPV vaccines market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Global IPV vaccines market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The IPV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global IPV vaccines market
Detailed Segmentation:
  • Global IPV Vaccines Market, by Vaccine Brand:
  • Poliovac (Pfs/Sd)
  • Shanipv
  • Poliorix
  • Ipol/Imovax
  • Polymilex
  • Global IPV Vaccines Market, by Distribution Channel:
  • Private
  • Public
  • Global IPV Vaccines Market, by Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • GlaxoSmithKline Plc
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • PT Bio Farma
  • AJ Vaccines

Table of Contents

220 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Vaccine Brand
Market Snapshot, By Vaccine Type
Market Snapshot, By Vial Type
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map
3. Key Insights
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Company Market Share Analysis
Import-Export Analysis
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Epidemiology
Healthcare Spending, by Country
Vaccination Rate, by Country
Manufacturing Capacities
Distributors Landscape
Investments & Funding
Competitive Snapshot
Heat Map Analysis
4. Global IPV Vaccines Market, By Vaccine Brand, 2020 - 2032 (US$ Million)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2020 - 2032
Segment Trends
POLIOVAC (PFS/SD), 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
SHANIPV, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
POLIORIX, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
IPOL/IMOVAX, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
POLYMILEX, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
5. Global IPV Vaccines Market, By Vaccine Type, 2020 - 2032 (US$ Million)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2020 - 2032
Segment Trends
Combination Vaccine, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
Single Vaccine, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
6. Global IPV Vaccines Market, By Vial Type, 2020 - 2032 (US$ Million)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2020 - 2032
Segment Trends
1 Dose Vial, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
5 Dose Vial, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
10 Dose Vial, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
7. Global IPV Vaccines Market, By Distribution Channel, 2020 - 2032 (US$ Million)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032
Market Y-o-Y Growth Comparison (%), 2020 - 2032
Segment Trends
Public, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
Private, 2020 - 2032(US$ Million)
Introduction
Market Size and Forecast, 2020 - 2032, (US$ Million)
8. Global IPV Vaccines Market, By Region, 2020 - 2032 (US$ Million)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Million)
Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Million)
Regional Trends
North America
Introduction
Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
Introduction
Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
GCC
Israel
Rest Of The Middle East
Africa
Introduction
Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Million)
South Africa
North Africa
Central Africa
9. Competitive Landscape
Competitive Snapshot
What Market Participants are Saying?
Competitive Dashboard
Company Market Share Analysis, 2025 - Global
10. Company Profiles - Global IPV Vaccines Market
Sanofi*
Company Overview
Product/Service Portfolio
Financial Performance
Recent Developments/Updates
Strategic Overview
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Merck & Co., Inc.
GlaxoSmithKline
AJ Vaccines A/S
Panacea Biotec
Biken
Sinopharm Group Co. Ltd.
Nanolek
IMBCAMS
Sinovac Biotech
LG Chem
Beijing Minhai Biological Technology Co., Ltd.
Biological E Limited.
Section 10: Wheel of Fortune
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. References and Research Methodology
References
Research Methodology
About us and Sales Contact

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us